These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18473895)

  • 21. [Anti-viral immune responses against hepatitis C virus].
    Imawari M
    Uirusu; 2002 Jun; 52(1):151-6. PubMed ID: 12227166
    [No Abstract]   [Full Text] [Related]  

  • 22. Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy.
    Li W; Krishnadas DK; Li J; Tyrrell DL; Agrawal B
    J Immunol; 2006 May; 176(10):6065-75. PubMed ID: 16670315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune responses to hepatitis C virus (HCV) infection and the prospects for an effective HCV vaccine or immunotherapies.
    Lauer GM
    J Infect Dis; 2013 Mar; 207 Suppl 1():S7-S12. PubMed ID: 23390305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospects for prophylactic and therapeutic vaccines against hepatitis C virus.
    Feinstone SM; Hu DJ; Major ME
    Clin Infect Dis; 2012 Jul; 55 Suppl 1():S25-32. PubMed ID: 22715210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hepatic immune system.
    Wick MJ; Leithäuser F; Reimann J
    Crit Rev Immunol; 2002; 22(1):47-103. PubMed ID: 12186188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contradictory intrahepatic immune responses activated in high-load hepatitis C virus livers compared with low-load livers.
    Ishibashi M; Yamaguchi H; Hirotani Y; Sakurada A; Endo T; Sugitani M; Takayama T; Makishima M; Esumi M
    Arch Virol; 2018 Apr; 163(4):855-865. PubMed ID: 29248968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion?
    Hahn YS
    Curr Opin Immunol; 2003 Aug; 15(4):443-9. PubMed ID: 12900277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preservation of immune function and anti-hepatitis C virus (HCV) immune responses after liver transplantation in HIV-HCV coinfected patients (ANRS-HC08 "THEVIC" trial).
    Samri A; Roque-Afonso AM; Beran O; Tateo M; Teicher E; Feray C; Sebagh M; Guettier C; Dussaix E; Vittecoq D; Samuel D; Autran B; Duclos-Vallée JC
    J Hepatol; 2009 Dec; 51(6):1000-9. PubMed ID: 19833404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cell response in hepatitis C virus infection.
    Neumann-Haefelin C; Blum HE; Chisari FV; Thimme R
    J Clin Virol; 2005 Feb; 32(2):75-85. PubMed ID: 15653409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein.
    Zabaleta A; Llopiz D; Arribillaga L; Silva L; Riezu-Boj JI; Lasarte JJ; Borrás-Cuesta F; Prieto J; Sarobe P
    Mol Ther; 2008 Jan; 16(1):210-7. PubMed ID: 17923840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immunopathogenesis of hepatitis C virus infection.
    Nelson DR
    Clin Liver Dis; 2001 Nov; 5(4):931-53. PubMed ID: 11685802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis.
    Ahmad A; Alvarez F
    J Leukoc Biol; 2004 Oct; 76(4):743-59. PubMed ID: 15218054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of T cell immunity in hepatitis C virus infections.
    Claassen MA; Janssen HL; Boonstra A
    Curr Opin Virol; 2013 Aug; 3(4):461-7. PubMed ID: 23735335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptive immune responses in acute and chronic hepatitis C virus infection.
    Bowen DG; Walker CM
    Nature; 2005 Aug; 436(7053):946-52. PubMed ID: 16107834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biology and significance of T-cell apoptosis in the liver.
    Park S; Murray D; John B; Crispe IN
    Immunol Cell Biol; 2002 Feb; 80(1):74-83. PubMed ID: 11869364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus-mediated modulation of cellular immunity.
    Brenndörfer ED; Sällberg M
    Arch Immunol Ther Exp (Warsz); 2012 Oct; 60(5):315-29. PubMed ID: 22911132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Success and failure of virus-specific T cell responses in hepatitis C virus infection.
    Neumann-Haefelin C; Thimme R
    Dig Dis; 2011; 29(4):416-22. PubMed ID: 21894013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of alloimmune T cell responses on hepatitis C virus replication in liver transplant recipients.
    Tanaka Y; Ohira M; Tashiro H; Imamura M; Chayama K; Ohdan H
    Hum Immunol; 2014 Dec; 75(12):1259-67. PubMed ID: 25300999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesized peptides 705-734 from hepatitis C virus E2 glycoprotein induce dendritic cell maturation by activating p38 MAPK signaling.
    Liu X; Chen N; Lin S; Liu M
    Int Immunopharmacol; 2016 Jan; 30():194-201. PubMed ID: 26604090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.